Chemomab Therapeutics Ltd. (CMMB) stock
CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.64+0.02 (+1.23%)
Close on Nov 17, 2026Market cap $11.80MP/E 1.1Yield –
Chemomab Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Chemomab Therapeutics's price to book ratio was 1.1× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.3× to 2.9×, with a median of 0.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.1× | +0.2 |
| 2025 | Dec 31, 2025 | 0.9× | −1.7 |
| 2024 | Dec 31, 2024 | 2.6× | +2.3 |
| 2023 | Dec 29, 2023 | 0.3× | −0.5 |
| 2022 | Dec 30, 2022 | 0.8× | −0.4 |
| 2021 | Dec 31, 2021 | 1.2× | −13.6 |
| 2020 | Dec 31, 2020 | 14.8× | +8.6 |
| 2019 | Dec 31, 2019 | 6.2× | – |
See a number that looks wrong?